Monthly archive | PharmaTutor

28 June 2026

Health Ministry Proposes Acknowledgement-Based Import System for Drug Testing Samples

the Ministry of Health and Family Welfare has proposed amendments to the Drugs Rules, 1945 to simplify the import procedure for drugs intended for examination, testing and analysis.

28 June 2026

Government Proposes Major Changes to Medical Devices Rules to Speed Up Licensing

The Ministry of Health and Family Welfare has released draft amendments to the Medical Devices Rules, 2017, proposing significant changes to reduce the time required for granting manufacturing licences for medical devices in India.

27 June 2026

Government Pharmacist Recruitment - 09 posts in District Health Society

Diploma In Pharmacy from a recognized institute. Registered under State Pharmacy Council. Computer proficiency (MS Office) & Internet.

27 June 2026

Advertisement for the post of Pharmacist at ECHS Central Organization

B.Pharmacy or Approved Diploma in Pharmacy from an Institute recognized by the Pharmacy Council of India and registered as Pharmacist. Minimum 03 years experience. The ECHS Central Organization is located at Delhi and functions under the Chief of Staff Committee through AG and DGDC&W in Army HQ.

27 June 2026

Apply Online for Quality Manager at PAREXEL - Work from Home opportunity

Bachelors Degree required preferably in life sciences or health-related discipline or equivalent experience.

27 June 2026

IQVIA Require Clinical Data Specialist

Provide basic and some comprehensive data management expertise to the Clinical Data Management (CDM) team to provide efficient, quality data management products that meet customer needs.

27 June 2026

Eli Lilly Launches Tanstrive in India, Expanding Precision Treatment Options for RET-Altered Cancers

Eli Lilly and Company India has announced the launch of Tanstrive (selpercatinib) in India following marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO). The targeted therapy is indicated for patients with locally advanced or metastatic solid tumours driven by rearranged during transfection (RET) gene alterations, offering a new precision medicine option for eligible cancer patients.

27 June 2026

USFDA Completes Pre-License Inspection at Dr. Reddy's Bachupally Biologics Facility; Issues Form 483 with Seven Observations

Dr. Reddy's Laboratories Limited has informed the stock exchanges that the United States Food and Drug Administration (USFDA) has completed a Pre-License Inspection (PLI) at the company's biologics manufacturing facility located in Bachupally, Hyderabad.

According to the company's regulatory filing, the inspection was conducted from June 16 to June 25, 2026. At the conclusion of the inspection, the USFDA issued a Form 483 containing seven observations.

26 June 2026

CDSCO Announces Permanent Drug Inspector Recruitment - 186 Openings

Bachelors degree in Pharmacy or Pharmaceutical Sciences or Medicine with specialization in Clinical Pharmacology or Microbiology from a recognized University or institute.